Oxford Asset Management’s Novartis NVS Stock Holding History

Oxford Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-26,602	Closed	-$1.74M	–	1451
2016 Q4	$1.74M	Buy	26,602 +18,379	+224%	+$1.19M	0.06%	365
2016 Q3	$582K	Buy	+8,223	New	+$599K	0.02%	603
2015 Q3	–	Sell	-10,810	Closed	-$953K	–	697
2015 Q2	$953K	Buy	+10,810	New	+$992K	0.03%	450
2013 Q3	–	Sell	-73,217	Closed	-$4.64M	–	873
2013 Q2	$4.64M	Buy	+73,217	New	+$4.76M	0.13%	261

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Oxford Asset Management's NVS Position: Q1 2017 in Review

Oxford Asset Management sold out of Novartis (NVS) in Q1 2017, closing a stake of 26,602 shares — an estimated $1.74M sold.

Oxford Asset Management first reported a position in NVS in Q2 2013 and held it in 4 quarters. The position peaked at $4.64M in Q2 2013. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Oxford Asset Management reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
Oxford Asset Management sold 26,602 Novartis shares in Q1 2017, an estimated $1.74M.
Oxford Asset Management first reported a position in Novartis in Q2 2013 and held it in 4 quarters.
Oxford Asset Management's Novartis position peaked at $4.64M in Q2 2013.
910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Oxford Asset Management's 13F filing for Q1 2017, filed 9 May 2017.